Palisade Bio, Inc. (PALI) vs Rocket Pharmaceuticals, Inc. (RCKT)
- Palisade Bio, Inc. PALI 1.41 −8.44%
- Rocket Pharmaceuticals, Inc. RCKT 2.18 −7.63%
Palisade Bio, Inc. and Rocket Pharmaceuticals, Inc. are both Biotechnology companies. Palisade Bio, Inc. and Rocket Pharmaceuticals, Inc. are of similar size ($268.4M and $259.1M). Rocket Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Palisade Bio, Inc. trades at 2.2×. Rocket Pharmaceuticals, Inc. has the higher net margin (0.00% vs −4,230.6%) and the lower return on invested capital (−114.7% vs 0.00%). Across the 14 metrics below, Palisade Bio, Inc. leads on 7 and Rocket Pharmaceuticals, Inc. on 7.
Valuation
Profitability
| Metric | PALI | RCKT | Biotechnology median |
|---|---|---|---|
| Gross margin | 95.63% | 0.00% | 65.16% |
| Operating margin | (4,681.99%) | 0.00% | 0.00% |
| Net margin | (4,230.60%) | 0.00% | 0.00% |
| Free cash flow margin | (2,409.27%) | 0.00% | 0.00% |
| Return on equity | (51.37%) | (4.77%) | (56.36%) |
| Return on assets | (47.68%) | (4.09%) | (48.04%) |
| Return on invested capital | 0.00% | (114.71%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack